Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Interest & Investment Income (2023 - 2024)

SELLAS Life Sciences (SLS) has disclosed Interest & Investment Income for 5 consecutive years, with $181000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Interest & Investment Income rose 341.46% to $181000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $632000.0, a 51.98% decrease, with the full-year FY2024 number at $632000.0, up 20.38% from a year prior.
  • Interest & Investment Income was $181000.0 for Q4 2024 at SELLAS Life Sciences, down from $221000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $221000.0 in Q3 2024 to a low of $41000.0 in Q4 2023.